Find your care
Cancer care begins with research. It guides us to new and better ways of detecting, diagnosing and treating lung cancer.
At UCLA Health, we are leaders in lung cancer research, finding new ways to personalize treatment and treat cancer effectively. Our researchers and physicians work closely together to incorporate the newest lung cancer findings into your care. We offer promising targeted therapies through clinical trials to give you access to new and innovative treatments before they’re widely available.
Search the clinical trials offered at UCLA Health.
Why are lung cancer clinical trials important?
Clinical trials are critical in the development of promising drugs and treatments. They help researchers and physicians understand how and when new medicines work best and what to expect throughout the treatment.
For patients, clinical trials provide an opportunity to:
- Access promising new treatments before they’re widely available
- Get expert medical care at a leading health center during the trial
- Help others by contributing to the advancement of lung cancer treatment
- Increase treatment options if standard treatments aren’t working
Lung cancer research: the UCLA Health advantage
The National Cancer Institute (NCI) recognizes UCLA Health as a comprehensive cancer center with a distinct lung cancer research program. While in our care, you can expect:
Access to clinical trials: In addition to standard treatment, your lung cancer team will offer you the opportunity to participate in clinical trials whenever appropriate.
Compassionate support: Our oncology (cancer) navigators are by your side every step of the way to help you find the resources and support you need. If you experience side effects during your clinical trial, the Simms/Mann Center for Integrative Oncology offers support programs to help you manage those symptoms.
High recognition for research: The NCI recognizes UCLA Health as a Specialized Program of Research Excellence (SPORE) in lung cancer. They support our research into new lung cancer treatments and therapies.
Leaders in lung cancer research: We’re part of the Lung Cancer Mutation Consortium (LCMC), a nationwide group of leading cancer centers who study lung cancer mutations (changes) to develop new targeted and personalized treatments.
Wide-reaching availability: In addition to our UCLA Health locations, more than 15 community oncology practices across Southern California and multiple states offer UCLA Health clinical trials. Those practices are affiliated with the UCLA Jonsson Comprehensive Cancer Center as part of a network called Translational Research in Oncology-US (TRIO-US).
How research impacts our lung cancer care
We root our lung cancer care in advanced research. Not only are our physicians engaged in researchunderstand how research personalizes lung cancer treatment.
When appropriate, our physicians offer investigational treatments through clinical trials as options for your care plan. We give you immediate access to the newest immunotherapy, targeted therapy and innovative treatment strategies while providing forward-thinking, personalized care at every stage of your disease.